Bacteria in head and neck tumor stimulate immunotherapy resistance by attracting immune cells and creating a shield.
Cleveland Clinic researchers have discovered that bacteria inside cancerous tumors may be key to understanding why ...
As of December 31, 2025, the cumulative installed base of the SSi Mantra totaled 168 systems, including 12 systems deployed across nine countries outside of India. To date, 153 hospitals have ...
“This collaboration underscores our belief in zanzalintinib’s potential to drive patient benefit in combination with immunotherapy or targeted therapy in HNSCC and RCC indications that have unmet ...
Genmab will stop development of its experimental antibody therapy to treat cancer that was in late-stage trials, the Danish ...
The goal of the Head and Neck Oncology/Endocrine team in the UAB Department of Otolaryngology is to provide outstanding patient care in a compassionate, innovative, and user-friendly manner. The range ...
In more recent decades, HPV has been shown as a risk factor for developing head and neck cancer. Head and neck cancer covers everything from throat, tongue, and tonsil cancer to laryngeal, mouth, and ...
Head and neck cancers represent 4% of U.S. cancer cases, with significant mortality rates, highlighting the need for awareness and early detection. These cancers affect multiple anatomical sites, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback